EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Examining the role of thromboelastography in patients with COVID-19

Alexander L Chen iD, Matthew Robbins, Sean Masters iD, Elizabeth Boudiab, Daniel Finn, Emanuela Peshel, Gregory Thomas, Diane Studzinski, Steven Truscott, Courtney Watterworth, Nathan Novotny, Felicia Ivascu und 1 weitere

Perfusion · 2026

DOI: 10.1177/02676591251340967 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Perfusion, 2026. Verfasst von Alexander L Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA. Hauptthemen laut MEDLINE: Thrombelastography, COVID-19, Thrombophilia, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Gurwin Family Surgical Research and Education Endowment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 causes a severe respiratory distress syndrome. Systemic inflammation and hypercoagulability are common. These findings are often evaluated with non-specific markers, including CRP, D-dimer, and fibrinogen. We sought to evaluate thromboelastography (TEG) to better understand this complex coagulopathy.

Methods

We conducted a prospective observational study analyzing TEG results in hospitalized patients with COVID-19. TEG was performed on admission and at pre-set intervals. Based on the TEG findings, patients were deemed “hypercoagulable” or “not hypercoagulable.” Clinical outcomes were recorded.

Results

88 patients were evaluated. 78/88 (89%) were hypercoagulable. 10% of the hypercoagulable group (8/78) died compared to none in the non-hypercoagulable group (0/10), with thrombotic events occurring in 9% (8/88), a higher requirement for O2 support in 19% (17/88), and prolonged length of stay exceeding 4 days for 74% (65/88). No statistical significant differences were observed between the groups for any of the four adverse events. Patients with complete fibrinolysis shutdown (Ly30 = 0) had more thrombotic events than those with Ly30 > 0 (30% vs 0%, p = .03).

Conclusion

Patients with COVID-19 are often hypercoagulable based upon specific TEG parameters. While many TEG parameters are not associated with adverse outcomes, complete fibrinolysis shutdown is associated with an increased risk of thrombotic events. Further studies are warranted to assess the utility of TEG in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombelastographyCOVID-19ThrombophiliaSARS-CoV-2HumansMaleFemaleMiddle AgedAgedProspective StudiesThrombosisAdult

Stichwörter der Autor:innen

COVID-19TEGcoagulopathyfibrinolysis shutdownthromboelastography

Autor:innen und Institutionen

  • Department of General Surgery, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.
  • Special Chemistry and Toxicology Laboratories, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.
  • Beaumont Research Institute, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.

ORCID-Profile: Alexander L Chen, Sean Masters

Förderung

  • Gurwin Family Surgical Research and Education Endowment

Zitieren

APA

Chen, A. L., Robbins, M., Masters, S., Boudiab, E., Finn, D., Peshel, E., Thomas, G., Studzinski, D., Truscott, S., Watterworth, C., Novotny, N., Ivascu, F., & Iacco, A. (2026). Examining the role of thromboelastography in patients with COVID-19. Perfusion. https://doi.org/10.1177/02676591251340967

Vancouver

Chen AL, Robbins M, Masters S, Boudiab E, Finn D, Peshel E, et al. Examining the role of thromboelastography in patients with COVID-19. Perfusion. 2026. doi:10.1177/02676591251340967

BibTeX
@article{Chen2026,
  author = {Chen, Alexander L and Robbins, Matthew and Masters, Sean and Boudiab, Elizabeth and Finn, Daniel and Peshel, Emanuela and Thomas, Gregory and Studzinski, Diane and Truscott, Steven and Watterworth, Courtney and Novotny, Nathan and Ivascu, Felicia and Iacco, Anthony},
  title = {Examining the role of thromboelastography in patients with COVID-19},
  journal = {Perfusion},
  year = {2026},
  doi = {10.1177/02676591251340967}
}
Kostenlos starten →